Where Edwards Lifesciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Edwards Lifesciences (NYSE:EW) has received positive analyst ratings in the last quarter, with 7 bullish and 6 somewhat bullish ratings. The average 12-month price target for the company has increased by 7.04% from the previous average, now standing at $97.0.
July 14, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings often influence investor sentiment. The positive ratings for Edwards Lifesciences indicate a positive outlook for the company, which could lead to increased investor interest and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100